Completed Genetics & Molecular Biology Cells, Biochemistry & Physiology

Leveraging genetic variation to understand chromosome pairing, meiosis and the evolution of human disease risk

In plain English

AI plain-English summary

Every time a human egg or sperm cell forms, chromosomes must pair up and swap genetic material with precision—when this process goes wrong, it causes infertility, miscarriage, cancer, and developmental disorders. This project aims to uncover the genetic controls that govern that pairing, known as synapsis, and the recombination that follows, by exploiting natural genetic variation in both fertile and infertile people. The researchers will also map how the genome’s physical structure and gene activity change during meiosis, using single-cell techniques to track which proteins orchestrate each step and how genetic differences alter the outcome. Separately, they will build evolutionary trees from hundreds of thousands of modern and ancient human genomes, using recombination-driven changes along the DNA to trace how disease-risk variants arose and how natural selection has shaped them over time. This is fundamental science: it will not produce a treatment tomorrow. But understanding the basic mechanics of chromosome pairing and the evolutionary history of disease variants could eventually inform fertility diagnostics, cancer risk prediction, and therapies for chromosomal disorders—much as past discoveries in meiosis laid the groundwork for prenatal screening and assisted reproduction.

View original technical description
We have the following specific aims: 1. To discover how normal pairing (synapsis) of homologous chromosomes during mammalian meiosis is genetically controlled in fertile and infertile individuals, and how synapsis first initiates, and then spreads. To do this, we will leverage naturally occurring genetic variation. Errors in recombination, and in synapsis, result in aneuploidy events, and chromosomal rearrangements due to NAHR, that cause many human disorders including infertility, pregnancy loss, cancer, and developmental syndromes. 2. To quantify how the chromatin accessibility and gene expression environments change during meiosis, using single-cell ATAC and RNA sequencing, and learn how proteins binding to DNA coordinate the onset and progression of meiosis, recombination, synapsis and impact fertility, and are impacted by genetic variation and chance. 3. To build from our existing approaches to understand population structure, in order to infer trees revealing the historical relationships relating hundreds of thousands of modern and ancient individuals, in humans and other recombining species. We will use these trees, which change along the genome due to recombination, to investigate how variation impacting complex diseases and other traits has arisen and been acted upon by natural selection, how selection changes through time, and how the rate of evolution itself evolves through time.

View the original record at the funder ↗

Researchers

Simon Myers (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Development of statistical and experimental approaches to understand the roles of recombination and migration in human biology and disease risk.
Structural basis of meiotic chromosome organization by the synaptonemal complex.
The causes and consequences of sex differences in meiotic recombination.
Adaptive evolution of meiosis in response to genome and habitat change
Molecular basis of chromosome synapsis and genetic exchange in mammalian meiosis

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.